Optimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer.

Meador CB, Jin H, de Stanchina E, Nebhan CA, Pirazzoli V, Wang L, Lu P, Vuong H, Hutchinson KE, Jia P, Chen X, Eisenberg R, Ladanyi M, Politi K, Zhao Z, Lovly CM, Cross DA, Pao W
Mol Cancer Ther. 2015 14 (2): 542-52

PMID: 25477325 · PMCID: PMC4338015 · DOI:10.1158/1535-7163.MCT-14-0723

MeSH Terms (18)

Acrylamides Afatinib Aged Aniline Compounds Animals Antibodies, Monoclonal, Humanized Cell Line, Tumor Cell Proliferation Cetuximab Drug Resistance, Neoplasm ErbB Receptors Humans Lung Neoplasms Male Mice, Nude Molecular Targeted Therapy Mutation Quinazolines

Connections (2)

This publication is referenced by other Labnodes entities: